This may be due to the direct inhibition of erythroid differentiation by TME or some cytokines from tumor cells [46], as well as the significant decrease in EPO concentration in tumor patients, which blocks the differentiation pathway from EPCs to erythrocytes [46], increasing EPCs in peripheral blood and a decrease in mature erythroid cells. The gene discussed is EPO; the disease is neoplasm.